Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $41.87 -0.36%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
NSYS, PLNH, SPRU, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
NSYS, PLNH, SPRU, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.35), in-line with the analyst estimate of ($0.35). Revenue for the quarter came in at $1.15 million versus the consensus estimate of $550 thousand.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
- EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
- MaxCyte, Inc. (MXCT) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
